GLP-1 receptor agonists hold key market opportunities due to their effectiveness in diabetes and obesity management, ...

GLP-1 receptor agonist-related agonism may prevent addiction phenotypes across all major drug classes according to authors of a recent study.

Opportunities in the GLP-1 receptor agonist market include the development of new diabetes and obesity treatments with high ...

Researchers at the University of California San Diego have uncovered how a single protein triggers two opposite responses in blood vessels—one inflammatory and one protective. This protein, a ...

Post-diagnosis weight gain over ~1.5 years is consistently associated with increased breast cancer–specific and all-cause mortality across meta-analyses. How GLP-1 weight-loss drugs fit after breast ...

As key molecules on the surface of immune cells, Fc receptors are the core hub of antibody-mediated effector functions. They play an irreplaceable role in physiological processes such as ...

Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other ...

Weill Cornell Medicine researchers have determined the full-length structure of a blood pressure-regulating hormone receptor for the first time, uncovering how it functions, which may enable better ...